Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Prospective, uncontrolled, investigator-initiated, phase II clinical study to explore the activity of trabectedin in a population of patients aged ≥16 years with progressive, advanced (locally advanced or metastatic)
Epistemonikos ID: 6961a25a0bda141ce176cfdbc15531d45ac3acbd
First added on: May 07, 2024